The 20 Best Non-Alcoholic Fatty Liver Disease Doctors Near Me in Nottingham, MD

Saleh Alqahtani is a Gastroenterologist practicing medicine in Baltimore, Maryland. Dr. Alqahtani is rated as an Elite provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Non-Alcoholic Fatty Liver Disease, Obesity, Hepatitis, Liver Transplant, and Hepato-Pancreato-Biliary Surgery.

James Tonascia is a Radiologist practicing medicine in Baltimore, Maryland. Dr. Tonascia is rated as an Elite provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Non-Alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis (NASH), and Deep Brain Stimulation.

Douglas Brunner is a Radiologist practicing medicine in Baltimore, Maryland. Dr. Brunner is rated as an Experienced provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. His clinical expertise encompasses Pleural Effusion, Pleurisy, Chronic Cough, and Lung Nodules.

Ann Morrill is an Internal Medicine provider practicing medicine in Nottingham, Maryland. Dr. Morrill is rated as an Experienced provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Hypothyroidism, Obesity in Children, Vitamin B12 Deficiency, and Type 2 Diabetes (T2D). Dr. Morrill is currently accepting new patients.

Joseph Lin is a Gastroenterologist practicing medicine in Rosedale, Maryland. Dr. Lin is rated as an Experienced provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Cronkhite-Canada Disease, Attenuated Familial Adenomatous Polyposis, Juvenile Polyposis Syndrome, and Lactose Intolerance.

Adline Ghazi is an Endocrinologist practicing medicine in Baltimore, Maryland. Dr. Ghazi is rated as undefined provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Thyroid Hormone Plasma Membrane Transport Defect, and Generalized Resistance to Thyroid Hormone.

Elizabeth Chacko is an Endocrinologist practicing medicine in Baltimore, Maryland. Dr. Chacko is rated as undefined provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. Her clinical expertise encompasses Postmenopausal Osteoporosis, Osteoporosis, Thyroid Nodule, and Type 2 Diabetes (T2D).

Errol Rushovich is an Endocrinologist practicing medicine in Nottingham, Maryland. He has been practicing medicine for over 44 years. Dr. Rushovich is rated as an Experienced provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Hypothyroidism, Obesity in Children, Type 2 Diabetes (T2D), and Osteoporosis.

Natarajan Ravendhran is a hepatologist specializing in the diagnosis, treatment and management of liver diseases. He received his medical degree from Stanley Medical College, University of Madras in India, completed his residency in internal medicine at what is now Ascension Saint Agnes Hospital in Maryland and a residency in surgery at Railway Hospital in Madras, India. Dr. Ravendhran performed fellowship training in hepatology under the mentorship of Eugene and Leon Schiff at the University of Miami. Additionally, he received fellowship training in gastroenterology and liver disease at the University of Missouri. Dr. Ravendhran received a master’s degree in business administration in medical services management from The Johns Hopkins University. He is a fellow of the American Association for the Study of Liver Diseases and the American Gastroenterological Association, and is a member of the European Association for the Study of the Liver. Dr. Ravendhran is interested in exploring cholestatic disorders. He has participated in many clinical trials that focus on hepatitis B and C, in addition to metabolic dysfunction-associated steatotic liver disease trials. He enjoys teaching, rounding with fellows and seeing patients, and his motto is “Patients come first!”. Dr. Ravendhran is rated as a Distinguished provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Non-Alcoholic Fatty Liver Disease, Hepatitis, Visceromegaly, Enlarged Liver, and Endoscopy. Dr. Ravendhran is board certified in American Board Of Internal Medicine.

Anurag Maheshwari is a Gastroenterologist practicing medicine in Nottingham, Maryland. Dr. Maheshwari is rated as an Advanced provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Hepatitis, Autoimmune Hepatitis, Nonalcoholic Steatohepatitis (NASH), Endoscopy, and Colonoscopy.

Mark Corriere is an Endocrinologist practicing medicine in Towson, Maryland. Dr. Corriere is rated as undefined provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Thyroid Nodule, and Hypothyroidism. Dr. Corriere is board certified in American Board Of Internal Medicine.

Dr. Sudipa Sarkar is an assistant professor of medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include endocrinology. She received her M.D. from Yale School of Medicine. She completed her residency in internal medicine at Yale-New Haven Hospital and performed a fellowship in endocrinology, diabetes and metabolism at Vanderbilt University Medical Center. Dr. Sarkar joined the Johns Hopkins faculty in 2017. Dr. Sarkar is rated as an Experienced provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Type 2 Diabetes (T2D), Diabetic Retinopathy, Maturity Onset Diabetes of the Young, Diabetic Neuropathy, and Sleeve Gastrectomy. Dr. Sarkar is board certified in American Board Of Internal Medicine.

Mihail “Misha” Zilbermint, M.D., M.B.A., F.A.C.E. is an Associate Professor of Clinical Medicine at the Division of Endocrinology, Diabetes and Metabolism, Johns Hopkins School of Medicine. He is the Director of Endocrine Hospitalists at the Johns Hopkins Community Physicians, Chief and Director of Division of Endocrinology, Diabetes and Metabolism at Suburban Hospital in Bethesda, MD. Dr. Zilbermint is known for pioneering the Endocrine Hospitalist program at Johns Hopkins Medicine following the completion of his endocrinology fellowship at the National Institutes of Health. This consultation service is dedicated to enhancing glycemic control among hospitalized patients, effectively reducing patient stays and saving the hospital hundreds of thousands of dollars. His commitment to innovation earned his specialized diabetes team the Johns Hopkins Innovations in Clinical Care Award. Over the years, Dr. Zilbermint has been sought after for his expertise in endocrinology and diabetes, with a focus on inpatient diabetes management, diabetic ketoacidosis (DKA), Hyperosmolar Hyperglycemic State (HHS), and diabetes technology. His reputation extends nationally and internationally, as he is often invited to speak at conferences and is sought after for consultations worldwide. His extensive research interests encompass diabetes initiatives, hypoglycemia reduction, continuous glucose monitoring (CGM) systems, COVID-19 vaccines and hyperglycemia, COVID-19 and diabetes, genetic causes of hypertension, primary aldosteronism, rare adrenal tumors, and the interplay between diabetes and climate change. Dr. Zilbermint leads the JHCP Academy Clinical Excellence, which helps to recognize and promote clinical excellence about community-based clinicians. Beyond his clinical and research contributions, Dr. Zilbermint is a dedicated educator. He imparts his expertise to endocrinology fellows, hospitalists, pharmacy residents, and advanced practice providers, furthering the advancement of the medical community. CVhttps://www.hopkinsmedicine.org/-/media/profiles-support/cvs/zilbermint.pdfLinkedInhttps://www.linkedin.com/in/mishazilbermint. Dr. Zilbermint is rated as undefined provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Cushing's syndrome, Familial Hyperaldosteronism, Hyperaldosteronism, Low Blood Sugar, and Thymectomy. Dr. Zilbermint is board certified in American Board Of Internal Medicine.

Dr. Prasanna Santhanam received his M.B.B.S. from B.J. Medical College and his M.D. from N.H.L. Municipal Medical College. He completed a residency in internal medicine, Joan C Edwards School of Medicine, Marshall University and a fellowship in endocrinology, diabetes, and metabolism at Joan C Edwards School of Medicine, Marshall University. He underwent additional training in nuclear medicine, at the Department of Radiology and Radiological Sciences at Johns Hopkins University School of Medicine, to pursue his research and clinical interests in nuclear medicine and molecular imaging of endocrine glands and disorders. His clinical interests include thyroid disorders, endocrine neoplasms, and research focus on metabolic and molecular imaging of endocrine tissues and predictive analytics in metabolic disorders. Dr. Santhanam is rated as undefined provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Thyroid Cancer, Follicular Thyroid Cancer, Papillary Thyroid Cancer, Anaplastic Thyroid Cancer, and Thyroidectomy.

Justin Tcheugui is an Endocrinologist practicing medicine in Baltimore, Maryland. Dr. Tcheugui is rated as an Experienced provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Gestational Diabetes, and Type 1 Diabetes (T1D). Dr. Tcheugui is board certified in American Board Of Internal Medicine.

Dr. Han Na Kim is a Clinical Associate and part-time Assistant Professor of Medicine in the Division of Endocrinology, Diabetes, and Metabolism. Her clinical practice focuses on metabolic bone disease, including osteoporosis and hyperparathyroidism, as well as diabetes mellitus. She earned her medical degree from the University of Chicago Pritzer School of Medicine, completed her residency in Internal Medicine at New York University, and worked as a hospitalist at University of Pittsburgh Medical Center Presbyterian/Montefiore before pursuing an endocrinology fellowship at Johns Hopkins University School of Medicine. She sees patients at the Johns Hopkins Bayview Metabolic Bone and Osteoporosis Center and Green Spring Station Johns Hopkins Endocrinology Clinic (diabetes and thyroid patients only). Dr. Kim is rated as an Experienced provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. She is also highly rated in 22 other conditions, according to our data. Her clinical expertise encompasses Postmenopausal Osteoporosis, Osteoporosis, Juvenile Primary Osteoporosis, and Hyperparathyroidism. Dr. Kim is board certified in American Board Of Internal Medicine.

Jennifer Mammen, M.D., Ph.D., Assistant Professor of Medicine, is a member the Division of Endocrinology, Diabetes and Metabolism. Dr. Mammen practices general endocrinology with a focus on thyroid, adrenal and pituitary disorders. She is actively engaged in research on hormonal function and aging. Dr. Mammen is rated as undefined provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Hyperthyroidism, Hypothyroidism, Thyroid Storm, Graves Disease, and Hormone Replacement Therapy (HRT).

Dr. Kendall Moseley is the Clinical Director of the Division of Diabetes, Endocrinology & Metabolism, Medical Director of the Johns Hopkins Metabolic Bone & Osteoporosis Center and Co-Director of the Johns Hopkins Multidisciplinary Parathyroid Clinic. Dr. Moseley received her medical degree from Baylor College of Medicine in Houston, TX, followed by internal medicine residency training at the Johns Hopkins Hospital. Upon completion of her endocrinology fellowship at Johns Hopkins, she joined the faculty in the Division of Endocrinology, Diabetes & Metabolism of the Johns Hopkins University School of Medicine. Dr. Moseley has a dynamic clinical practice and collaborations within the institution that focus on metabolic bone diseases, osteoporosis, hyperparathyroidism, vitamin D deficiency, atypical fractures, and skeletal survivorship. She is actively engaged in NIH-funded clinical and translational research involving the relationship between type 2 diabetes, osteoporosis, and aging. She is additionally involved in research investigating mechanisms by which chronic disease states such as malignancy, HIV, hepatitis C, and cystic fibrosis impact bone quantity and quality. Clinically, she enjoys partnering with her patients and using their unique and often complex medical history to individually tailor effective diet, lifestyle, and treatment regimens to improve skeletal health. Dr. Moseley is rated as undefined provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Osteoporosis, Postmenopausal Osteoporosis, Paget's Disease of Bone, and Hyperparathyroidism.

Dr. Ronadip (Ron) Banerjee is an Associate Professor in the Division of Endocrinology, Diabetes and Metabolism at Johns Hopkins University School of Medicine. His clinical interests include Endocrine Tumors, such as Multiple Endocrine Neoplasia, adrenal tumors and disorders, pancreatic and neuroendocrine tumors, pituitary, thyroid and parathyroid disorders. Dr. Banerjee received his B.S. in Biological Sciences with. Dr. Banerjee is rated as undefined provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Multiple Endocrine Neoplasia Type 1, Multiple Endocrine Neoplasia, Gestational Diabetes, and Adrenal Insufficiency Pediatric. Dr. Banerjee is board certified in American Board Of Internal Medicine.

Dr. Ulrike M. Hamper is a Professor in the Johns Hopkins Medicine Department of Radiology and Radiological Science. She also holds appointments in the Department of Pathology and Department of Urology. Her clinical interests include image-guided interventional procedures and encompass the entire spectrum of sonographic studies. These include vascular, OB/GYN, abdominal, genitourinary, pediatric and musculoskeletal ultrasound, as well as imaging of the thyroid, neck and scrotum. Dr. Hamper earned her medical degree at Germany’s Thesis University of Bonn. She completed a pathology residency at the University of Cologne and a rotating medical/surgical internship at Bonn’s Malteser Hospital—both also in Germany. At The Johns Hopkins Hospital, Dr. Hamper completed a residency in diagnostic radiology and fellowship in ultrasound, computed tomography, nuclear medicine and cardiovascular radiology. She also holds a Master of Science in Business degree and an M.B.A. in medical services management, both from Johns Hopkins University. Dr. Hamper has published scores of articles, conducted approximately 20 funded research studies and presented nearly 100 invited lectures. Dr. Hamper is rated as an Experienced provider by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Melorheostosis with Osteopoikilosis, Melorheostosis, Osteopenia, and Premature Ovarian Failure. Dr. Hamper is board certified in American Board Of Radiology.